Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NxThera Inc.

www.nxthera.com

Latest From NxThera Inc.

De-Risking China For Foreign Life Science Investors

With $1 billion under management, Hong Kong-based private equity firm Ally Bridge Group bagged multiple deals in 2015 including WuXi's $3.3 billion privatization. ABG's CEO Frank Yu talks about pursuing a holistic approach that goes beyond ABG's China roots.

BioPharmaceutical Medical Device

Medical Device Deals Update, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced November-December 2015.

Medical Device Deals

Venture Funding Deals, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2015.

BioPharmaceutical Medical Device

INTERVIEW: Ally Bridge CEO On De-Risking China And Investing In 2016

With $1bn under management, the Hong Kong private equity firm Ally Bridge Group bagged multiple deals in 2015 including WuXi's $3.3bn privatization. CEO Frank Yu spoke to PharmAsia News about pursuing a holistic approach that goes beyond its China roots.

China Deals
See All

Company Information

  • Industry
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cancer
  • Gynecological, Urological
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NxThera Inc.
  • Senior Management
  • J. Robert Paulson, CEO
    Carmen Bringgold, SVP, Commercialization & CFO
    Maximillian D Fiore, Chief Dev. & Operations Officer
    Michael Hoey, CTO
    Kari Cierzan, Dir., Mktg.
  • Contact Info
  • NxThera Inc.
    Phone: (763) 515-0404
    7351 Kirkwood Lane North
    Ste. 138
    Maple Grove, MN 55369
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register